No single blood type has the strongest immune system. Each ABO type carries a distinct portfolio of advantages and vulnerabilities that shift depending on which pathogen or immune challenge you face. Blood type O, for instance, offers striking protection against severe malaria but leaves you more exposed to cholera. The A and B antigens on red blood cells do double duty as molecular docking stations that pathogens exploit or that the immune system uses defensively, and evolution has kept all four major types in circulation for millions of years precisely because none of them wins across the board.
Why Evolution Has Not Picked a Winner
If one blood type truly conferred a superior immune system, natural selection would have driven the others to extinction long ago. Instead, the ABO polymorphism has been maintained by a process called balancing selection for tens of millions of years, making it one of the oldest known examples of this kind of genetic maintenance outside of the immune system’s own major histocompatibility complex.
Research on primate genomes has shown that the A and B blood groups represent a trans-species polymorphism shared among distantly related primates, not something that arose independently in humans.
1PubMed Central. The ABO blood group is a trans-species polymorphism in primates The leading explanation is that shifting or fluctuating selection pressures, likely driven by co-evolution with gut pathogens, have kept all the alleles in play.2PubMed Central. Ancestry runs deeper than blood: the evolutionary history of ABO points to cryptic variation of functional importance Additional blood group genes beyond ABO also show signs of balancing selection driven by pathogens, reinforcing the idea that blood type diversity is an immune strategy, not an accident.3PubMed Central. Widespread balancing selection and pathogen-driven selection at blood group antigen genes
In plain terms, the reason all four blood types persist is that the “best” type keeps changing depending on where you live, which infections are circulating, and what other immune pressures exist. A blood type that protects against one deadly disease can make you more vulnerable to another.
Malaria and the Advantage of Type O
The clearest example of a blood type conferring meaningful immune protection involves type O and severe malaria. In a matched study of children in Mali, type O appeared in only about a fifth of severe malaria cases compared with roughly 44% of both uncomplicated malaria cases and healthy controls. After adjusting for other factors, type O was linked to about a two-thirds reduction in the odds of developing severe malaria compared with non-O types.4PubMed Central. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting
The mechanism is physical. The malaria parasite Plasmodium falciparum causes infected red blood cells to clump together with uninfected ones, a process called rosetting that blocks blood flow and worsens disease. The A and B antigens on red blood cell surfaces act like molecular handles that help these clumps form. Type O cells lack those handles, so rosettes form less efficiently and break apart more easily. In regions where malaria has historically been a major killer, this protection is significant enough to have driven type O to higher frequencies in local populations.
Cholera Flips the Script
If you only looked at malaria data, you might conclude that type O is the immune champion. But cholera tells the opposite story. People with blood type O who become infected with Vibrio cholerae are more likely to develop severe illness. A study in an area where cholera is common found that household contacts with type O had roughly double the odds of severe disease if infected, compared with other blood types.5PubMed Central. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity
Laboratory work has started to explain why. Cholera toxin needs to latch onto a specific receptor on gut lining cells to do its damage. The A and B blood group antigens, when present on those cells, appear to interfere with this binding, acting almost like decoys. In experiments with human intestinal tissue, cells expressing the O blood group showed a much larger toxic response to cholera toxin than cells from blood group A individuals.6PubMed Central. Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera So the very thing that makes type O protective against malaria, the absence of A and B surface sugars, makes it a liability against cholera. This is the evolutionary balancing act at work.
What COVID-19 Revealed (and Did Not Reveal)
Early in the pandemic, headlines declared that type O offered protection against COVID-19. The reality is more nuanced. A meta-analysis pooling data from dozens of studies found that people with type O had a modestly lower rate of initial SARS-CoV-2 infection compared with non-O types, with about a 19% reduction in odds. However, that same analysis found no evidence that type O protected against severe disease once someone was already infected.7PubMed Central. ABO blood group and COVID-19: an updated systematic literature review and meta-analysis
A large study tracking patients across multiple dominant variant waves confirmed this pattern from a different angle: the proportion of severe disease among all four blood types was essentially identical, hovering around 8.6 to 8.9%, with no statistically significant differences during any variant period.8PubMed Central. Association between ABO blood type and coronavirus disease 2019 severe outcomes across dominant variant strains One study did find that Rh-negative individuals had a slightly lower risk of initial infection and of intubation or death, and that blood type AB was associated with increased risk of both intubation and death relative to type O.9Nature Communications. Associations between blood type and COVID-19 infection, intubation, and death But the absolute differences between blood groups were estimated at somewhere between 0.1% and 8.2% after accounting for race and ethnicity, meaning blood type was a minor player compared with age, comorbidities, and vaccination status.
The COVID story is a useful illustration of why sweeping claims about blood type and immunity tend to collapse under scrutiny. Initial associations often shrink or vanish once confounding factors are properly controlled. A small statistical tilt in infection rates does not mean your blood type is shielding you from serious illness.
Stomach Bugs, Norovirus, and Secretor Status
Your ABO type is only part of the story when it comes to gut infections. Whether you are a “secretor,” someone who expresses blood group antigens on the mucosal surfaces of your gut and in saliva, matters just as much and sometimes more. About 80% of the population are secretors, determined by a gene called FUT2.10PubMed. Intersections of ABO blood group, secretor status, and the gut microbiome: implications for disease susceptibility and therapeutics
Norovirus, the most common cause of acute gastroenteritis worldwide, depends heavily on these mucosal blood group antigens to latch onto gut cells. The FUT2 gene is a key determinant of susceptibility to norovirus infection, and non-secretors are substantially more resistant to certain norovirus strains.11Journal of the Formosan Medical Association. Clinical significance of the fucosyltransferase 2 (FUT2) secretor status in children hospitalized with acute gastroenteritis in Taiwan Being a non-secretor essentially removes the molecular doorknob that the virus needs to enter your gut cells.
Helicobacter pylori, the bacterium behind most stomach ulcers and a driver of stomach cancer, also exploits blood group antigens on the stomach lining. H. pylori has evolved adhesion proteins that bind specifically to fucosylated blood group antigens and sialylated Lewis antigens on the mucosal surface.12PLOS Pathogens. Role of ABO Secretor Status in Mucosal Innate Immunity and H. pylori Infection Research has found that among people infected with H. pylori, those with blood group O who are also non-secretors have higher levels of inflammatory immune cells in their stomach lining compared with non-O non-secretors, suggesting that the combination of blood type and secretor status shapes both colonization and the body’s inflammatory response.13FEMS Immunology & Medical Microbiology. Effect of host Lewis and ABO blood group antigen expression on Helicobacter pylori colonisation density and the consequent inflammatory response
Clotting Factors, Inflammation, and the Non-O Penalty
Blood type influences immune function through pathways you might not expect, including blood clotting and vascular inflammation. Type O individuals naturally carry lower levels of von Willebrand factor (a clotting protein) and certain cell adhesion molecules compared with A, B, and AB types. Meanwhile, type O individuals have higher levels of soluble E-selectin, a molecule involved in recruiting immune cells to sites of inflammation.14PubMed Central. Altered DNA methylation of the ABO gene is associated with differential plasma levels of von willebrand factor and E‐selectin
A meta-analysis quantified part of this difference: levels of soluble E-selectin were over 40% lower in people carrying two copies of the O-associated allele compared with those homozygous for the non-O allele, with soluble P-selectin roughly 19% lower as well.15PubMed Central. Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis These molecules are part of the immune system’s communication network, directing white blood cells to where they are needed. Their levels affect how vigorously the body mounts an inflammatory response to injury or infection.
This clotting and inflammation gap widens with age. The age-related rise in von Willebrand factor and factor VIII is steeper in non-O individuals, meaning the difference between type O and non-O blood grows substantially over a lifetime.16PubMed Central. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms This has practical consequences: non-O types face higher risk of blood clots (deep vein thrombosis, pulmonary embolism, stroke), while type O’s lower clotting factor levels may contribute to slightly higher bleeding risk. In critical illness, blood type A has been associated with higher concentrations of markers tied to endothelial activation, the process that drives organ damage in sepsis and acute respiratory distress.17JCI Insight. The ABO histo-blood group, endothelial activation, and acute respiratory distress syndrome risk in critical illness
Autoimmune Diseases and Blood Type Patterns
A strong immune system is not just about fighting off infections — an overactive immune system that turns on your own tissues is its own problem. Research into autoimmune conditions and blood type has found patterns, though they are inconsistent across studies and populations. One study found that blood type A and Rh-positive status were more commonly observed in patients with rheumatic diseases, though the overall distribution of ABO groups among different rheumatic conditions was not statistically significant.18PubMed Central. Clinical Impact of the ABO Blood Type in Patients with Rheumatic Diseases: Is there a Link to the ABO and Rhesus?
A Turkish study found that which autoimmune disease was most common depended on the blood type: spondyloarthritis, vasculitis, and rheumatoid arthritis were more frequent in patients with type A, while lupus and scleroderma were more common in type O patients. Blood type AB had the lowest rates of autoimmune disease across the board in that study.19PubMed Central. ABO blood groups and rheumatic diseases A separate study found that autoimmune hemolytic anemia, where the body destroys its own red blood cells, was significantly more common in people with type B.20PubMed Central. ABO and Rh blood groups in patients with lupus and rheumatoid arthritis
These findings reinforce the broader theme: what looks like immune “strength” against one threat can manifest as immune overreaction in another context. The same surface antigens that help or hinder pathogen binding also influence how the immune system calibrates its response to self versus non-self.
Vaccine Responses Vary by Blood Type Too
If blood type affects how you respond to infections, it stands to reason that it might also affect how well vaccines work. A study of COVID-19 vaccine recipients found that blood type O was associated with better antibody persistence after inactivated-virus vaccines, while blood type A was linked to a higher antibody rise in recipients of adenoviral-vector vaccines. Rh-positive individuals also showed stronger antibody responses in some vaccine combinations.21PubMed. The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID-19 vaccine regimens
In the case of hepatitis B vaccine, a study of children in South Africa found a significant association between ABO blood type and the strength of antibody response. Having the B antigen, whether through type B or type AB, was associated with a weaker immune response to the vaccine.22Vaccine. ABO blood types, but not Secretor or Lewis blood types, influence strength of antibody response to Hepatitis B vaccine in Black South African children These are not differences large enough to change vaccination recommendations for any blood type, but they suggest that the immune system’s baseline tuning varies in subtle ways depending on which antigens your cells carry.
Cancer Risk and the H. pylori Connection
Immune surveillance, the body’s ability to detect and destroy abnormal cells before they become tumors, also shows blood-type patterns. One of the more robust findings links non-O blood types to higher pancreatic cancer risk. A population-based study found that having a non-O blood type was associated with about a 37% increase in the odds of pancreatic cancer. When combined with a certain H. pylori infection profile, the risk for non-O individuals nearly tripled, while type O individuals with the same infection showed no increased risk.23JNCI: Journal of the National Cancer Institute. ABO Blood Group, Helicobacter pylori Seropositivity, and Risk of Pancreatic Cancer: A Case–Control Study
The mechanism likely involves the same clotting and inflammatory pathways discussed earlier. Higher levels of von Willebrand factor and adhesion molecules in non-O types may create a more pro-inflammatory environment that, over decades, nudges certain tissues toward cancerous change. But type O is not universally cancer-protective either — earlier epidemiological work associated it with higher rates of certain other conditions, including some infections linked to chronic inflammation.
Beyond ABO — The Duffy System and Malaria
ABO is the blood group system most people think of, but it is far from the only one with immune implications. The Duffy blood group system offers perhaps the most dramatic example of blood-type-based immune protection in all of human genetics. The Duffy antigen serves as a receptor that the malaria parasite Plasmodium vivax uses to invade red blood cells. People who lack the Duffy antigen entirely, a phenotype common in populations of West and Central African descent, are essentially resistant to P. vivax infection.24PubMed. Duffy blood group and malaria
This is not a subtle statistical tilt like the ABO-COVID association; it is near-complete protection against a specific pathogen, driven by the loss of the receptor the parasite needs. The Duffy-negative phenotype has risen to near fixation in malaria-endemic regions of Africa, a textbook case of pathogen-driven natural selection. Research into the Duffy system has been explored as a potential pathway toward a malaria vaccine, since blocking the same receptor interaction the parasite depends on could replicate the natural protection that Duffy-negative individuals enjoy.25PubMed Central. Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention
Your Gut Microbiome Has a Blood Type Preference
Your blood type and secretor status also help determine which microbes colonize your gut, which in turn shapes your baseline immune function. In secretors, ABO antigens are expressed on the mucosal surfaces of the gastrointestinal tract, where they act as attachment points and even nutrient sources for specific bacterial families. Research has found that being a secretor is associated with less microbial diversity at higher levels of classification, while specific bacterial groups expand or contract depending on which blood group antigens are present.26PubMed Central. Relationships between gastrointestinal microbiota and blood group antigens
Particular bacterial taxa show clear preferences. Members of the Lachnospiraceae family, which include butyrate-producing bacteria important for gut barrier health, are found at higher levels in secretors. People with the A antigen show a distinct microbial profile, with lower levels of certain beneficial genera and higher levels of others, compared to non-A secretors.26PubMed Central. Relationships between gastrointestinal microbiota and blood group antigens Since the gut microbiome influences everything from nutrient absorption to immune training to inflammation levels, these blood-type-driven differences in bacterial colonization represent yet another pathway through which your blood type subtly shapes immune function without any single type emerging as universally superior.
The Rh Factor Adds Another Layer
Most conversations about blood type immunity focus on ABO, but the Rh system carries its own set of immune interactions. The most familiar consequence is hemolytic disease of the newborn, where an Rh-negative mother carrying an Rh-positive baby can mount an immune response against fetal blood cells. Beyond pregnancy, Rh status has been investigated for its interaction with the parasite Toxoplasma gondii, which chronically infects roughly a third of the global population.
One study found that the effect of Toxoplasma infection on physical performance depended on Rh status: Rh-negative individuals who were infected showed lower performance on grip strength and endurance tests, while Rh-positive infected individuals actually performed slightly better than their uninfected peers.27PubMed Central. Lower performance of Toxoplasma-infected, Rh-negative subjects in the weight holding and hand-grip tests The researchers behind related work on Rh and Toxoplasma’s effects on sensory function noted their own sample sizes were small enough that findings about Rh interactions should be treated as preliminary.28PubMed Central. Latent toxoplasmosis and olfactory functions of Rh positive and Rh negative subjects Still, the pattern is intriguing: Rh-positive status may buffer against some of the negative effects of chronic Toxoplasma infection, adding to the growing picture that every element of your blood type profile fine-tunes your immune response in ways specific to the threats you encounter.
The honest takeaway is that asking which blood type has the “strongest” immune system is a bit like asking which Swiss Army knife is the best — it depends entirely on what you need to cut. Each blood type represents a different trade-off in the ancient, ongoing negotiation between humans and the pathogens that have co-evolved alongside us.